News » Latest Articles
Browse All Categories
James Francum
By James Francum on June 11, 2021

The Quality Systems (QS) Regulations of FDA 21 CFR 820 are general standards that apply to finished devices, that are intended for human use. Rather than impose strict requirements, the regulations offer an opportunity to the manufacturers of these devices to incorporate their quality management standards into key organizational processes.

By Julian Oberle
on June 02, 2021

Let’s start this piece with a question for ourselves: do we still need password expiration as a security measure? In today’s life science industry, especially the pharmaceutical sector, a number of compliance reasons, guidelines, and agency regulations are responsible for an organization’s requirement to have their employees change their passwords every so often. It is now fair to say that we arrived at a point in time where most of the reasons behind the password expiration policy seem obsolete. 

James Francum
By James Francum
on May 19, 2021

According to a report from the US Food and Drug Administration (FDA), major deficiency letters were issued to 67% of premarket approval applications. Such deficiencies in applications can hold up premarket approvals - sometimes more than 180 days.

James Francum
By James Francum
on May 03, 2021

You have received one of the dreaded FDA Warning Letters. The last thing you want is to delay the launch of your company's latest innovation. However, you cannot risk shutdown for non-compliance and the possibility of never making it to market with your latest brainchild. 

Dr. Ulrich Köllisch
By Dr. Ulrich Köllisch
on April 26, 2021


The ICH E6 Good Clinical Practice Guideline is a cornerstone in today’s guidance for Good Clinical Practice (GCP). The guidance addresses an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects. With the goal to provide a unified standard for all ICH regions to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions. As of March 2021, the newest revision R3 is in a draft state, so we took the opportunity to run down the important aspects of Data Integrity and Data Governance inside the first iteration of the ICH E6 GCP principles.

Vinicius Tarantino
By Vinicius Tarantino
on April 09, 2021

Our last Webinar about data integrity was a great success, and we thank you all for the questions and participation. We believe we can bring value to the industry when we collaborate to give insights and share solutions to our customers' challenges within compliance in Life Science.

Dr Zuhdi Hussein
By Dr Zuhdi Hussein
on March 31, 2021

The CAPA process from the side of regulatory compliance of both U.S. FDA requirements (21 CFR 820.100) and EU regulatory requirements (ISO 13485, 8.5.2) is one of the most important elements of a Quality Management System (QMS). 

It is essential to develop a system the right way to assure QMS effectiveness and minimize irregular findings on regulatory audits.

Roberto Orlandini
By Roberto Orlandini
on March 09, 2021


Blockchain is the technology that created the 128 Bi cryptocurrency market, which is at the heart of Bitcoin and other virtual currencies such as Ethereum, Tether, and more. The Blockchain is an open, distributed ledger that can record transactions between two or more entities in an efficient, verifiable, and permanent way. The ledger itself can also be programmed to trigger transactions automatically (smart contracts).

Chong Yang Gue
By Chong Yang Gue
on February 16, 2021

Speed. It is the deciding factor between hundreds or millions of death cases. In a pandemic, speed is everything. The World Health Organization's (WHO) emergencies program executive director Michael Ryan, a doctor experienced in the Ebola outbreak, rightly said in a COVID-19 press conference that speed trumps everything else in an emergency response. Speed defines life or death. Governments, people, and especially the pharmaceutical sectors must embrace the speed to conquer a pandemic. Countries that are slower to respond are paying a huge price. Speed is everything that includes the pharmaceutical industry as well. What if we could make the vaccine available to the majority within one month instead of 18 months? 

Dr. Anjana Venkataramanan
By Dr. Anjana Venkataramanan
on February 08, 2021

This is part 2 of a 2-part article series on Data Integrity trends in 2020. Find the link to part-1 here.